These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 21939364)

  • 1. Development of a method of clozapine dosage by selective electrode to the iodides.
    Teyeb H; Douki W; Najjar MF
    Drug Chem Toxicol; 2012 Jul; 35(3):272-6. PubMed ID: 21939364
    [TBL] [Abstract][Full Text] [Related]  

  • 2. QTc prolongation and clozapine: fact or artefact?
    Nielsen J
    Aust N Z J Psychiatry; 2012 Aug; 46(8):793-4. PubMed ID: 22492267
    [No Abstract]   [Full Text] [Related]  

  • 3. Clinical predictors of serum clozapine levels in patients with treatment-resistant schizophrenia.
    Rajkumar AP; Poonkuzhali B; Kuruvilla A; Jacob M; Jacob KS
    Int Clin Psychopharmacol; 2013 Jan; 28(1):50-6. PubMed ID: 23104241
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Usefulness of heart rate variability (HRV) for monitoring clozapine plasma levels.
    Agelink MW; Sayar K; Klieser E
    Pharmacopsychiatry; 2003 Jul; 36(4):166-7; authors reply 168. PubMed ID: 12905104
    [No Abstract]   [Full Text] [Related]  

  • 5. [Addition of fluvoxamine to clozapine: theory and practice].
    Wigard ME; van Gool AR; Schulte PF
    Tijdschr Psychiatr; 2013; 55(2):113-21. PubMed ID: 23408363
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The relationship between serum clozapine concentrations and hematological parameters by a validated mass spectrometric method.
    Kamil Gharab KM; Onmaz DE; Abusoglu S; Aydin M; Sivrikaya A; Tok O; Abusoglu G; Unlu A
    J Pharm Biomed Anal; 2020 Feb; 180():113056. PubMed ID: 31887669
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Toxic plasma concentration of clozapine in inflammatory processes].
    van Gool AR; de Jong MH; Verhoeven WM
    Tijdschr Psychiatr; 2010; 52(11):791-6. PubMed ID: 21064022
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adsorptive stripping voltammetric quantification of the antipsychotic drug clozapine in bulk form, pharmaceutical formulation and human serum at a mercury electrode.
    Hammam E; Tawfik A; Ghoneim MM
    J Pharm Biomed Anal; 2004 Sep; 36(1):149-56. PubMed ID: 15351059
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The clinical utility of therapeutic drug monitoring for clozapine.
    Bastiampillai T; Allison S; Gupta A
    Aust N Z J Psychiatry; 2017 Mar; 51(3):295-296. PubMed ID: 27920062
    [No Abstract]   [Full Text] [Related]  

  • 10. [Clozapine--the neglected potential].
    Munitz H
    Harefuah; 2012 May; 151(5):298-300, 318, 317. PubMed ID: 22844735
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modafinil-associated clozapine toxicity.
    Dequardo JR
    Am J Psychiatry; 2002 Jul; 159(7):1243-4. PubMed ID: 12091210
    [No Abstract]   [Full Text] [Related]  

  • 12. Therapeutic drug monitoring-based clozapine dosing recommendations.
    Zernig G; Ng K; Hiemke C; Saria A
    Ther Drug Monit; 2007 Feb; 29(1):130-1. PubMed ID: 17304162
    [No Abstract]   [Full Text] [Related]  

  • 13. Sexual disturbances during clozapine and haloperidol treatment for schizophrenia.
    Hummer M; Kemmler G; Kurz M; Kurzthaler I; Oberbauer H; Fleischhacker WW
    Am J Psychiatry; 1999 Apr; 156(4):631-3. PubMed ID: 10200746
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Local monitoring center for clozapine (Leponex) treatment].
    Bakken K; Bratlid T; Erlandsen C; Lingjaerde O; Nome S
    Tidsskr Nor Laegeforen; 1998 Mar; 118(7):1076-8. PubMed ID: 9531833
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum level of clozapine and relapse.
    Ulrich S; Wolf R; Staedt J
    Ther Drug Monit; 2003 Apr; 25(2):252-5. PubMed ID: 12657924
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Blood Draw Barriers for Treatment with Clozapine and Development of a Point-of-Care Monitoring Device.
    Kelly DL; Ben-Yoav H; Payne GF; Winkler TE; Chocron SE; Kim E; Kitchen C; Stock V; Vyas G; Love RC; Wehring HJ; Sullivan KM; Feldman S; Liu F; McMahon RP; Ghodssi R
    Clin Schizophr Relat Psychoses; 2018; 12(1):23-30. PubMed ID: 26218235
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clozapine treatment: Ensuring ongoing monitoring during the COVID-19 pandemic.
    Nystazaki M; Alevizopoulos G
    Psychiatriki; 2021 Jul; 32(2):165-166. PubMed ID: 33759812
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapeutic drug monitoring of clozapine in adults with schizophrenia: a review of challenges and strategies.
    Molden E
    Expert Opin Drug Metab Toxicol; 2021 Oct; 17(10):1211-1221. PubMed ID: 34461790
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clozapine induced akathisia: a case report and review of the evidence.
    Grover S; Sahoo S
    Indian J Pharmacol; 2015; 47(2):234-5. PubMed ID: 25878393
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Higher plasma drug concentration in clozapine-treated schizophrenic patients with side effects of obsessive/compulsive symptoms.
    Lin SK; Su SF; Pan CH
    Ther Drug Monit; 2006 Jun; 28(3):303-7. PubMed ID: 16778711
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.